FY2025 EPS Estimate for BioLineRx Increased by Analyst
BioLineRx Ltd. (NASDAQ:BLRX – Free Report) – Equities researchers at HC Wainwright boosted their FY2025 EPS estimates for shares of BioLineRx in a note issued to investors on Monday, March 31st. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of ($3.52) per share for the year, up from their […]
BioLineRx Ltd. (NASDAQ:BLRX – Free Report) – Equities researchers at HC Wainwright boosted their FY2025 EPS estimates for shares of BioLineRx in a note issued to investors on Monday, March 31st. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will post earnings of ($3.52) per share for the year, up from their […]